Real-time enrollment status for this hepatocellular carcinoma (hcc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:59 AM UTC
| NCT Number | NCT06726161 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma (HCC) |
| Phase | Clinical Trial |
| Target Enrollment | 590 participants |
| Active Locations | 13 sites in the US |
| Sponsor | RayzeBio, Inc. |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 13, 2026: Clinical trial NCT06726161 is currently recruiting participants. This clinical trial study for hepatocellular carcinoma (hcc) is actively seeking new participants at 13 locations across the United States. The study is sponsored by RayzeBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06726161 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06726161 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.